Skip to main content
Clinical Trials/NCT01136811
NCT01136811
Terminated
Not Applicable

Safety and Efficacy of Computer Assisted Surgery for Use in Vascular Surgery Procedures

University of Chicago2 sites in 1 country11 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lower Extremity Occlusive Disease
Sponsor
University of Chicago
Enrollment
11
Locations
2
Primary Endpoint
Patency of Graft Anastomosis
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the preliminary safety and efficacy of the daVinci surgical system (computer-assisted surgery) for use in vascular surgery procedures. Although the daVinci Surgical System is FDA approved and widely used for surgical procedures for urology, cardiac, general, and gynecologic procedures, it is not currently approved specifically for use in vascular surgery and the FDA has required the PI to conduct a small feasibility study under an IDE. The investigators are seeking approval by the FDA to utilize the daVinci Surgical System in vascular surgery and to conduct a future clinical trial.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
March 2011
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with significant femoropopliteal or tibial occlusive disease not amenable to catheter directed therapy (ie angioplasty/stenting). Symptoms include lifestyle-limiting claudication, rest pain and/or tissue loss.
  • Patients with an ABI between 0.2 and 0.
  • Femoropopliteal disease visible on color duplex ultrasound (DUS)
  • Patent and minimally diseased common femoral and proximal superficial artery
  • Patients with American Society of Anesthesiology (ASA) I, II or III classification
  • PT/PTT, EKG, HbA1c, liver function, within normal ranges within 30 days prior to procedure or stable over the last 6 months.
  • Current University of Chicago Medical Center Lab standards will be used. Pulmonary function will be assessed as needed by preoperative anesthesia evaluation. (Generally for infrainguinal procedures, pulmonary function is not assessed)
  • Body Mass Index (BMI) \<40

Exclusion Criteria

  • Previous surgery in the inguinal region (ie: prior femoral artery dissection)
  • Myocardial infarction (MI) within the last 6 months
  • Laboratory evidence of hypercoagulable state and/or connective tissue disease
  • Pregnant women
  • History of non-compliance with medical care

Outcomes

Primary Outcomes

Patency of Graft Anastomosis

Time Frame: 30 Day

Secondary Outcomes

  • Death(30day, 1 year)
  • Time for Femoral Artery Dissection and Anastomosis(1 day)
  • Improvement in ABI Measurement of 0.15 or Better(3 month, 6 month, 1 year)

Study Sites (2)

Loading locations...

Similar Trials